Michael A Brehm

Michael A Brehm is a Professor holding the Harvey A. Shultz Chair in Diabetes at UMass Chan Medical School, where he serves in multiple capacities across the T.H. Chan School of Medicine and Morningside Graduate School of Biomedical Sciences. His primary appointment is in the Program in Molecular Medicine, with additional affiliations in Pathology, Cancer Biology, Immunology and Microbiology, and various graduate programs including the Interdisciplinary Graduate Program and MD/PhD Program.

Brehm earned his BS in Microbiology from Philadelphia College of Pharmacy and Science and completed his PhD in Microbiology/Immunology at Pennsylvania State College of Medicine. His research career has focused on immunology, diabetes, and the development of humanized mouse models for studying human diseases.

Brehm's research interests center on understanding immune responses in the context of diabetes, transplantation, and cancer. His work has pioneered the development and application of humanized mouse models to study human-specific immune responses, viral infections, and autoimmune diseases. He has made significant contributions to our understanding of T cell biology, heterologous immunity, and the mechanisms underlying type 1 diabetes development. His laboratory has been instrumental in developing improved models for studying human immune responses to pathogens and in testing novel immunotherapies.

Analysis of Brehm's recent publications reveals a strong focus on immunology and translational research, with particular emphasis on humanized mouse models for studying diabetes, cancer immunology, and transplantation. His work spans from basic immunological mechanisms to preclinical testing of novel therapeutics. The publications show increasing collaboration with clinical researchers and expanding applications of humanized mouse technology to diverse disease areas including infectious diseases, autoimmune disorders, and cancer.

• Extensive research on humanized mouse models for studying human immune responses
• Significant contributions to understanding type 1 diabetes pathogenesis
• Development of novel models for studying transplantation immunology
• Investigation of T cell responses in viral infections and heterologous immunity

Throughout his career, Brehm has mentored numerous students and postdoctoral fellows across multiple graduate programs at UMass Chan Medical School. His laboratory has secured substantial grant funding to support its research on humanized mouse models and their application to human diseases. Brehm has been actively involved in collaborative research networks including the NIDDK Human Islet Research Network (HIRN), contributing to multi-institutional efforts to advance diabetes research.

Brehm leads a research team focused on humanized mouse model development and application, working closely with colleagues including Leonard Shultz and Dale Greiner. His laboratory continues to innovate in the field of human immune system modeling, with recent work expanding into cancer immunotherapy, organ transplantation, and infectious disease research using these sophisticated models.